Novel aspects of excitation-contraction coupling in heart failure.
about
Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablationIonizing radiation regulates cardiac Ca handling via increased ROS and activated CaMKII.Cardiovascular remodelling in coronary artery disease and heart failure.Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytesMyocardial energetics in heart failure.Dysregulation of Mfn2 and Drp-1 proteins in heart failure.Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.Epigenetics of the failing heart.A multidimensional sight on cardiac failure: uncovered from structural to molecular level.Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations.Ca(2+) cycling properties are conserved despite bradycardic effects of heart failure in sinoatrial node cells.Improvement of cardiomyocyte function by a novel pyrimidine-based CaMKII-inhibitor.Reduction of SR Ca2+ leak and arrhythmogenic cellular correlates by SMP-114, a novel CaMKII inhibitor with oral bioavailability.Special issue "Novel perspectives on heart failure".Tumor necrosis factor alpha protects heart cultures against hypoxic damage via activation of PKA and phospholamban to prevent calcium overload.Expression of ryanodine receptor mRNA and sarcoplasmic Ca²⁺-ATPase mRNA in the myocardium and intracellular reorganization of cardiomyocytes in dyslipidemia and during verapamil treatment.Rat engineered heart tissue: a novel tool in the safety pharmacology toolkit?
P2860
Q26864767-1F06B37E-1267-4C13-9CF4-F4AA3C94C963Q30566320-569CA2F8-26EA-4552-87C4-89001474592BQ35090566-014914D6-438C-4FDF-B1D7-DA035FAD0D69Q36511011-1A993224-6ACB-428D-B4A6-6DEDFD956E1BQ38112349-51FB05B5-B437-41E9-8397-1F3F681CE33AQ38218183-A0FBE7AE-A489-4C26-98ED-4B72EDC3FF09Q38246367-7731BD55-53B5-4755-ACFA-AE3A6A2D33AEQ38408408-6DF94D1E-245F-49B1-B958-8346C8317CBAQ39285223-ECC68F86-CAE7-4FAB-B2B4-1C4BB0CACED3Q39443185-52CAB838-3FAB-411E-AFE9-69B50EE61666Q41984222-00EC1F67-B6A6-4705-86AA-E2229202EF14Q47237820-7D832ADB-641F-4571-915E-9CF478DA3913Q48282087-2DE51E6E-BD20-4A47-9F0A-32F4CEEC06F6Q48773294-9D1D8B58-4501-4798-949C-D18158EA1EDFQ51688058-2C1B4903-258B-401A-A07D-4F9DF2293EE8Q52965001-D9123E85-DA03-4D81-A96D-AC781ADE0884Q53450193-B4D3F4C1-D914-4C0B-A160-31CE7DBA84AC
P2860
Novel aspects of excitation-contraction coupling in heart failure.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Novel aspects of excitation-contraction coupling in heart failure.
@ast
Novel aspects of excitation-contraction coupling in heart failure.
@en
Novel aspects of excitation-contraction coupling in heart failure.
@nl
type
label
Novel aspects of excitation-contraction coupling in heart failure.
@ast
Novel aspects of excitation-contraction coupling in heart failure.
@en
Novel aspects of excitation-contraction coupling in heart failure.
@nl
prefLabel
Novel aspects of excitation-contraction coupling in heart failure.
@ast
Novel aspects of excitation-contraction coupling in heart failure.
@en
Novel aspects of excitation-contraction coupling in heart failure.
@nl
P2860
P1476
Novel aspects of excitation-contraction coupling in heart failure.
@en
P2093
Lars S Maier
Stefan Neef
P2860
P2888
P356
10.1007/S00395-013-0360-2
P577
2013-06-06T00:00:00Z
P6179
1020792724